Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00605930 · ClinicalTrials.gov registry record · NA
A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00605930 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 20 participants.
The verdict
NCT00605930, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study intends to study the safety and tolerance of the combination of pyruvate, creatine, and niacinamide over 6 months in patients with PSP.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Pyruvate, creatine, niacinamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-04 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00605930
The ClinicalTrials.gov registry entry for NCT00605930 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00605930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00605930 about?
NCT00605930 is a clinical study titled "A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.". This study intends to study the safety and tolerance of the combination of pyruvate, creatine, and niacinamide over 6 months in patients with PSP.
What is the current status of trial NCT00605930?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2004-04. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00605930?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Pyruvate, creatine, niacinamide (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00605930?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.